Guided Therapeutics, Inc. Stock Forecast
Guided Therapeutics, Inc. stock downgraded to Sell Candidate
(Updated on Apr 30, 2024)
No changes to the price of Guided Therapeutics, Inc. stock on the last trading day (Tuesday, 30th Apr 2024). During the last trading day the stock fluctuated 0% from a day low at $0.109 to a day high of $0.109. The price has fallen in 4 of the last 10 days but is still up by 19.65% over the past 2 weeks.
The stock lies the upper part of a very wide and falling trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at $0.110 will firstly indicate a slower falling rate, but may be the first sign of a trend shift. Given the current short-term trend, the stock is expected to fall -41.87% during the next 3 months and, with a 90% probability hold a price between $0.0420 and $0.0638 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
GTHP Signals & Forecast
Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Guided Therapeutics, Inc. stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $0.113. On a fall, the stock will find some support from the short-term average at $0.101. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. A sell signal was issued from a pivot top point on Monday, April 29, 2024, and so far it has fallen 0%. Further fall is indicated until a new bottom pivot has been found. Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point". The very low volume increases the risk and reduces the other technical signals issued.
Support, Risk & Stop-loss for Guided Therapeutics, Inc. stock
On the downside, the stock finds support just below today's level from accumulated volume at $0.0960 and $0.0916. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Guided Therapeutics, Inc. finds support just below today's level at $0.0960. If this is broken, then the next support from accumulated volume will be at $0.0916 and $0.0873.
In general the stock tends to have very controlled movements and therefore the general risk is considered very low. However, be aware of low or falling volume and make sure to keep an eye on the stock During the last day, the stock moved $0 between high and low, or 0%. For the last week the stock has had daily average volatility of 9.40%
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (GTHP) For The Upcoming Trading Day Of Wednesday 1st
For the upcoming trading day on Wednesday, 1st we expect Guided Therapeutics, Inc. to open at $0.109, and during the day (based on 14 day Average True Range), to move between $0.0993 and $0.119, which gives a possible trading interval of +/-$0.0097 (+/-8.88%) up or down from last closing price. If Guided Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 17.75% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $0.116 (5.96%) than the support at $0.0960 (11.93%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Is Guided Therapeutics, Inc. stock A Buy?
Guided Therapeutics, Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Sell candidate.
Current score: -3.043 Sell Candidate Downgraded
Predicted Opening Price for Guided Therapeutics, Inc. of Wednesday, May 1, 2024
Fair opening price May 1, 2024 | Current price |
---|---|
$0.109 ( 0%) | $0.109 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for GTHP
Fibonacci Support & Resistance Levels
Level | Price | |||
---|---|---|---|---|
Resistance | R3 | 0.109 | . | |
R2 | 0.109 | . | ||
R1 | 0.109 | . | ||
Current price: | 0.109 | |||
Support | S1 | 0.109 | . | |
S2 | 0.109 | . | ||
S3 | 0.109 | . |
Accumulated Volume Support & Resistance Levels
Level | Price | |||
---|---|---|---|---|
Resistance | R3 | 0.132 | 21.10 % | |
R2 | 0.130 | 19.27 % | ||
R1 | 0.116 | 5.96 % | ||
Current price | 0.109 | |||
Support | S1 | 0.0960 | -11.93% | |
S2 | 0.0916 | -15.96% | ||
S3 | 0.0873 | -19.91% |
FAQ
Click here for our free guide on how to buy Guided Therapeutics, Inc. Stock.